Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 20 Feb 2025 for TherapeuticsMD, Inc.. Read the official filing
Filing timeline
BuySaleGail K. Naughton
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Gail K. Naughton: trading record in brief
Gail K. Naughton (board member) discloses dealings in 2 companies, chiefly TherapeuticsMD, Inc. and Bard C R Inc /NJ/. In total, 5 filings cover trades dated from 2 February 2016 to 18 February 2025.
No open-market purchase appears, only 2 sales worth €20k. The totals do not cover 1 filing with an undisclosed amount. The rest of the record consists of 3 option exercises.
On 20 February 2025 came the latest disclosure, an option exercise in TherapeuticsMD, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Gail K. Naughton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
8,500 shares0Common StockSEC:0000905148-25-000739:0
3,922 shares@ US$5.2614100.0% of flowCommon StockSEC:0001209191-22-060424:0
1,984 sharesCommon StockSEC:0001209191-22-046968:0
96,864 sharesCommon StockSEC:0001387131-21-008441:0
584 sharesCommon StockSEC:0001225208-16-025590:0
5 of 5 declarations
